Title
Category
Credits
Event date
Cost
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
Chronic kidney disease (CKD) is a complex condition requiring comprehensive management that includes appropriate medication therapy and interdisciplinary care coordination. This activity will discuss kidney- and cardiovascular-protective interventions for CKD and examine the roles of risk stratification, estimated glomerular filtration rate (eGFR) and urinary albumin creatinine ratio (uACR). In addition, considerations for the use of SGLT-2 inhibitors will be discussed, including heart failure status and adverse effects. Approaches to interdisciplinary care coordination for CKD that integrates nephrologists, primary care physicians, dietitians, and other health care professionals (HCPs) will be highlighted.
  • Disease management
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 Attendance - General Attendance
$0.00
Urinary tract infections (UTIs) are the most common infectious illness, particularly among individuals aged 65 years and older, and affect roughly 20% to 35% of women during their lifetime. UTIs contribute to 8 million ambulatory visits and 1 million hospitalizations annually in the US. This podcast will provide an overview of updated approaches to UTI detection, diagnosis and treatment; review common uropathogens; and highlight the distinctive challenges of UTIs related to infection characteristics and complications. Experts will share valuable insights through a discussion of evidence-based strategies to manage and prevent UTIs effectively.
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
Clinical practice guidelines are used in health care as an educational tool to improve patient care as a potential solution to reduce inappropriate variations in care. Opioid prescribing guidelines provide clear and comprehensive, evidence-based recommendations incorporating current information and practices for practitioners. This activity will examine the scope, impact, key statistics and factors contributing to the opioid crisis and highlight the current recommended opioid prescribing guidelines, their challenges and the role of state prescription drug monitoring programs (PDMP). Strategies to aid in implementing the opioid prescribing guidelines and to mitigate the opioid crisis will also be discussed.
  • Behavioral health
  • Pediatrics
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
The prevalence of anxiety within the pediatric population has increased over the past decade, and primary care pediatricians (PCPs) are often called on to manage and treat child and adolescent anxiety. This activity will discuss anxiety in the pediatric population, off-label use of medications for anxiety, and the “black box warning,” which warns the public of serious, permanent, and possibly fatal side effects caused by that medication. A treatment plan for a medication-naïve and a refractory, or treatment-resistant, patient with anxiety will also be highlighted.
  • Behavioral health
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
People at risk of suicide are often seen in health care settings, and health care organizations have a unique opportunity to identify and facilitate suicide prevention. Although there are long-standing clinical best practices, gaps still exist. Suicide Risk Formulation (SRF) is a process by which a clinician forms a judgment about a patient’s foreseeable risk of suicidal behavior based on data collected from a Suicide Risk Assessment (SRA). Risk formulation may indicate that enhanced interventions and increased support may be needed. Treatment should focus on reducing the immediate suicide risk and exploring any underlying mental-health and/or substance-use disorder. This activity is designed to support health care professionals through risk-mitigation situations by providing an advanced continuing education opportunity to improve practice, skills and knowledge.
  • Disease management
  • Wellness
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
Obesity is a chronic health condition and a leading cause of chronic diseases in adults and children. Lifestyle changes with the use of medication is a nonsurgical management strategy to promote weight loss and lessen the effects of these conditions caused or exacerbated by obesity. This activity will discuss how to effectively assess for obesity and provide nonsurgical management interventions through helping patients commit to lifestyle changes and the use of pharmacotherapies.
  • Oncology
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Bladder cancer (BC) is the tenth most common cancer worldwide, and its associated five-year survival rate declines rapidly (from 96% to 6%) as it progresses from in situ through local invasion, regional spread and finally to distal spread. Thus, early detection and timely therapeutic interventions are crucial to improve outcomes and reduce the burden of disease. Outcomes have been further improved by the integration of recently approved therapies for BC, the utilization of biomarkers to guide treatment plans and the opportunity for eligible patients with BC to enroll in clinical trials. For all treatment plans, effective communication among the health care team is crucial for providing comprehensive care for this condition. This activity will provide participants with an overview of early BC diagnosis and its impact on survival rates. It will explore recently approved therapies for BC both as standalone treatments and in combination with established therapeutic approaches. Emerging therapies and their potential benefits will be examined, and the value of biomarkers will be discussed. Participants will gain insight into treatment strategies to optimize patient outcomes in BC.
  • Behavioral health
  • Pediatrics
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Depression is one of the most common mental health disorders in children and adolescents, and the primary care provider is often the first point of contact for children and adolescents with depression. This activity will highlight the side effects of medications and drug interactions in treating depression and will discuss screening options for suicidality and how to create a basic safety plan.
  • Behavioral health
  • Disease management
  • Palliative care and hospice
  • 2.00 AMA - Physicians
  • 2.00 ANCC - Nurses
  • 2.00 Attendance - General Attendance
$0.00
Activity descriptionConversations that provide patients who have serious and life-threatening illnesses with the opportunity to make informed choices reflecting their goals, values and care preferences are a critical part of their care. These discussions can help ensure that seriously ill patients receive care that is consistent with their wishes and provide guidance to enhance family well-being and improve the patient’s quality of life.
  • Disease management
  • Vision
  • 1.00 AMA - Physicians
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will explore updated approaches to the management of glaucoma—the “silent thief of sight” that affects an estimated 3 million Americans. It will examine the latest evidence from recent studies on minimally invasive glaucoma surgery (MIGS) procedures and discuss comparative data on more invasive surgical techniques such as trabeculectomy and tube shunt surgery. Patient cases will be introduced to enhance participants’ understanding of the glaucoma treatment process. In addition, potential future innovations in glaucoma treatment will be discussed.

Pages